Get the Stockscreener App
0.9001
24.36%
0.1763
Pre-market:
.98
0.0799
+8.88%
Enveric Biosciences Inc Stock (ENVB) Forecast
The Enveric Biosciences Inc (ENVB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $124.61, representing a +13,744% increase from the current price of $0.9001. The highest analyst price target is $125.43, and the lowest is $123.80.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ENVB Price Target
Average 101.18
(+11,141% Upside)
Is Enveric Biosciences Inc (ENVB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 59.83 | Neutral |
| STOCH(9,6) | 51.35 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0433 | Buy |
| ADX(14) | 21.39 | Neutral |
| William %R | -2.8509 | Sell |
| CCI(14) | 188.45 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7145
Buy
|
0.7224
Buy
|
| MA20 |
0.6652
Buy
|
0.736
Buy
|
| MA50 |
0.9149
Sell
|
0.8779
Buy
|
| MA100 |
1.0897
Sell
|
1.1653
Sell
|
| MA200 |
1.7233
Sell
|
2.2928
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, ENVB could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on ENVB, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 59.83 indicates that ENVB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 51.35 indicates that ENVB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that ENVB is oversold. This suggests that ENVB price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.39 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 188.45 indicates that ENVB is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term ENVB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Enveric Biosciences Inc financial reports and earnings history, Enveric Biosciences Inc (ENVB) stock could reach $222.21 by 2030, $854.92 by 2040 and $324.20 by 2050. See the projected annual prices until 2050 of the Enveric Biosciences Inc stock below:
- Enveric Biosciences Inc (ENVB) is expected to reach an average price of $107.23 in 2035, with a high prediction of $120.50 and a low estimate of $107.36. This indicates an $11,814% rise from the last recorded price of $0.9001.
- Enveric Biosciences Inc (ENVB) stock is projected to chart a bullish course in 2040, with an average price target of $851.49, representing an $94,500% surge from its current level. The forecast ranges from a conservative $854.99 to a sky-high $854.92.
- Our analysts predict Enveric Biosciences Inc (ENVB) to jump 76,842% by 2045, soaring from $692.84 to an average price of $692.55, potentially reaching $711.15. While $692.84 is the low estimate, the potential upside is significant.
- Enveric Biosciences Inc (ENVB) stock is expected to climb by 2050, reaching an average of $300.10, a $33,241% jump from its current level. However, a wide range of estimates exists, with high and low targets of $324.20 and $300.41, respectively, highlighting the market's uncertainty.
Enveric Biosciences Inc Stock (ENVB) Year by Year Forecast
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2025
Enveric Biosciences Inc Stock (ENVB) is expected to reach an average price of $95.73 in 2025, with a high prediction of $136.31 and a low estimate of $55.14. This indicates an +10,535% rise from the last recorded price of $0.9001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2025 | $123.61 | $123.80 | $125.43 | +13,633% |
| December, 2025 | $117.07 | $118.38 | $120.61 | +12,906% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2026
The predicted value for Enveric Biosciences Inc (ENVB) in 2026 is set at an average of $91.30. Estimates vary from a peak of $115.64 to a trough of $66.96, indicating an +10,044% surge from the present price of $0.9001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $113.55 | $115.43 | $115.64 | +12,516% |
| February, 2026 | $111.86 | $112.19 | $114.40 | +12,328% |
| March, 2026 | $108.65 | $108.65 | $110.31 | +11,971% |
| April, 2026 | $104.94 | $105.01 | $106.45 | +11,558% |
| May, 2026 | $100.71 | $100.83 | $102.93 | +11,089% |
| June, 2026 | $96.34 | $96.47 | $99.23 | +10,604% |
| July, 2026 | $91.42 | $91.93 | $94.97 | +10,056% |
| August, 2026 | $86.07 | $86.22 | $89.61 | +9,462% |
| September, 2026 | $81.05 | $81.06 | $84.80 | +8,904% |
| October, 2026 | $76.83 | $76.94 | $79.83 | +8,436% |
| November, 2026 | $72.55 | $72.77 | $75.61 | +7,960% |
| December, 2026 | $64.81 | $66.96 | $70.84 | +7,101% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Enveric Biosciences Inc (ENVB) is $34.84, with a high forecast of $61.75 and a low forecast of $7.926. This indicates an +3,770% increase from the last price of $0.9001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $59.86 | $59.89 | $61.75 | +6,551% |
| February, 2027 | $56.24 | $56.41 | $58.40 | +6,148% |
| March, 2027 | $51.00 | $51.03 | $54.83 | +5,566% |
| April, 2027 | $46.77 | $46.79 | $48.46 | +5,096% |
| May, 2027 | $41.98 | $42.32 | $45.52 | +4,564% |
| June, 2027 | $36.84 | $36.89 | $40.71 | +3,993% |
| July, 2027 | $32.57 | $32.69 | $35.58 | +3,518% |
| August, 2027 | $27.98 | $28.04 | $31.36 | +3,008% |
| September, 2027 | $22.50 | $22.55 | $26.83 | +2,400% |
| October, 2027 | $18.34 | $18.56 | $21.35 | +1,938% |
| November, 2027 | $13.19 | $13.83 | $16.93 | +1,365% |
| December, 2027 | $7.926 | $7.926 | $11.60 | +780.57% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2028
In 2028, Enveric Biosciences Inc (ENVB) is projected to reach an average price of $147.44, with a high projection of $293.71 and a low estimate of $1.1679. This indicates an +16,280% rise from the last price of $0.9001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.4596 | $3.4988 | $6.5932 | +284.36% |
| February, 2028 | $251.85 | $1.1679 | $198.40 | +27,881% |
| March, 2028 | $219.93 | $223.43 | $242.07 | +24,334% |
| April, 2028 | $245.78 | $259.28 | $246.85 | +27,206% |
| May, 2028 | $298.85 | $270.43 | $277.85 | +33,102% |
| June, 2028 | $313.21 | $297.28 | $293.71 | +34,697% |
| July, 2028 | $280.57 | $282.57 | $276.85 | +31,071% |
| August, 2028 | $271.64 | $282.21 | $280.50 | +30,079% |
| September, 2028 | $283.00 | $286.50 | $281.28 | +31,341% |
| October, 2028 | $270.35 | $280.85 | $277.22 | +29,936% |
| November, 2028 | $254.93 | $237.78 | $239.43 | +28,222% |
| December, 2028 | $260.78 | $258.07 | $251.28 | +28,873% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2029
The 2029 price forecast for Enveric Biosciences Inc Stock (ENVB) is $256.79 on average, with a high prediction of $288.54 and a low estimate of $225.04. This represents an +28,429% increase from the previous price of $0.9001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $265.35 | $254.93 | $255.35 | +29,381% |
| February, 2029 | $269.71 | $271.57 | $268.71 | +29,865% |
| March, 2029 | $282.13 | $273.43 | $273.57 | +31,244% |
| April, 2029 | $279.43 | $280.43 | $280.56 | +30,944% |
| May, 2029 | $286.10 | $286.12 | $288.54 | +31,685% |
| June, 2029 | $273.35 | $273.85 | $281.46 | +30,269% |
| July, 2029 | $266.79 | $267.09 | $270.70 | +29,540% |
| August, 2029 | $258.99 | $260.68 | $264.08 | +28,673% |
| September, 2029 | $250.82 | $250.82 | $256.50 | +27,766% |
| October, 2029 | $240.75 | $240.93 | $246.85 | +26,647% |
| November, 2029 | $232.88 | $233.41 | $236.47 | +25,772% |
| December, 2029 | $224.87 | $225.04 | $228.74 | +24,883% |
Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2030
Enveric Biosciences Inc Stock (ENVB) is expected to reach an average price of $165.73 in 2030, with a high forecast of $222.21 and a low forecast of $109.25. This signifies an +18,312% surge from the last price of $0.9001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $215.01 | $215.06 | $222.21 | +23,787% |
| February, 2030 | $206.44 | $206.51 | $212.69 | +22,836% |
| March, 2030 | $197.62 | $197.91 | $204.07 | +21,855% |
| April, 2030 | $189.52 | $189.56 | $195.37 | +20,955% |
| May, 2030 | $177.33 | $177.50 | $187.16 | +19,601% |
| June, 2030 | $168.36 | $168.42 | $174.81 | +18,604% |
| July, 2030 | $157.79 | $157.88 | $165.94 | +17,430% |
| August, 2030 | $149.06 | $149.09 | $155.36 | +16,461% |
| September, 2030 | $139.24 | $139.56 | $146.40 | +15,370% |
| October, 2030 | $125.90 | $126.00 | $136.89 | +13,888% |
| November, 2030 | $117.34 | $117.64 | $122.79 | +12,936% |
| December, 2030 | $109.12 | $109.25 | $114.93 | +12,023% |
4.09%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):